Search

Your search keyword '"Molteni, Alfredo"' showing total 254 results
Start Over Author "Molteni, Alfredo"
254 results on '"Molteni, Alfredo"'

1. A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis

Author

Maffioli, Margherita, Mora, Barbara, Ball, Somedeb, Iurlo, Alessandra, Elli, Elena Maria, Finazzi, Maria Chiara, Polverelli, Nicola, Rumi, Elisa, Caramella, Marianna, Carraro, Maria Cristina, D'Adda, Mariella, Molteni, Alfredo, Sissa, Cinzia, Lunghi, Francesca, Vismara, Alessandro, Ubezio, Marta, Guidetti, Anna, Caberlon, Sabrina, Anghilieri, Michela, Komrokji, Rami, Cattaneo, Daniele, Della Porta, Matteo Giovanni, Giorgino, Toni, Bertù, Lorenza, Brociner, Marco, Kuykendall, Andrew, and Passamonti, Francesco

Published
2022
Full Text
View/download PDF

2. Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study

Author

Generali, Daniele, Bosio, Giancarlo, Malberti, Fabio, Cuzzoli, Antonio, Testa, Sophie, Romanini, Laura, Fioravanti, Antonio, Morandini, Alessandro, Pianta, Luca, Giannotti, Guglielmo, Viola, Erika Maria, Giorgi-Pierfranceschi, Matteo, Foramitti, Marina, Tira, Rosa Angela, Zangrandi, Ilaria, Chiodelli, Giulia, Machiavelli, Andrea, Cappelletti, Maria Rosa, Giossi, Alessia, De Giuli, Valeria, Costanzi, Chiara, Campana, Chiara, Bernocchi, Ottavia, Sirico, Marianna, Zoncada, Alessia, Molteni, Alfredo, Venturini, Sergio, Giudici, Fabiola, Scaltriti, Maurizio, and Pan, Angelo

Published
2021
Full Text
View/download PDF

3. Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination.—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda

Author

Rossi, G, Borlenghi, E, Zappasodi, P, Lussana, F, Bernardi, M, Basilico, C, Molteni, A, Lotesoriere, I, Turrini, M, Frigeni, M, Fumagalli, M, Cozzi, P, Gigli, F, Cattaneo, C, Fracchiolla, N, Riva, M, Martini, G, Mancini, V, Cairoli, R, Todisco, E, Rossi, Giuseppe, Borlenghi, Erika, Zappasodi, Patrizia, Lussana, Federico, Bernardi, Massimo, Basilico, Claudia, Molteni, Alfredo, Lotesoriere, Ivana, Turrini, Mauro, Frigeni, Marco, Fumagalli, Monica, Cozzi, Paola, Gigli, Federica, Cattaneo, Chiara, Fracchiolla, Nicola Stefano, Riva, Marta, Martini, Gianluca, Mancini, Valentina, Cairoli, Roberto, Todisco, Elisabetta, Rossi, G, Borlenghi, E, Zappasodi, P, Lussana, F, Bernardi, M, Basilico, C, Molteni, A, Lotesoriere, I, Turrini, M, Frigeni, M, Fumagalli, M, Cozzi, P, Gigli, F, Cattaneo, C, Fracchiolla, N, Riva, M, Martini, G, Mancini, V, Cairoli, R, Todisco, E, Rossi, Giuseppe, Borlenghi, Erika, Zappasodi, Patrizia, Lussana, Federico, Bernardi, Massimo, Basilico, Claudia, Molteni, Alfredo, Lotesoriere, Ivana, Turrini, Mauro, Frigeni, Marco, Fumagalli, Monica, Cozzi, Paola, Gigli, Federica, Cattaneo, Chiara, Fracchiolla, Nicola Stefano, Riva, Marta, Martini, Gianluca, Mancini, Valentina, Cairoli, Roberto, and Todisco, Elisabetta

Abstract

A retrospective survey was conducted in hematologic centres of the Rete Ematologica Lombarda (REL) on 529 older AML patients seen between 2020–2022. Compared to 2008–2016, the use of intensive chemotherapy (ICT) decreased from 40% to 18.1% and of hypomethylating agents (HMAs) from 19.5% to 13%, whereas the combination of Venetoclax/HMA, initially not available, increased from 0% to 36.7%. Objective treatment-specific fitness criteria proposed by SIE/SIES/GITMO in 2013 allow an appropriate choice between ICT and HMAs by balancing their efficacy and toxicity. Venetoclax/HMA, registered for patients unfit to ICT, has a unique toxicity profile because of prolonged granulocytopenia and increased infectious risk. Aiming at defining specific fitness criteria for the safe use of Venetoclax/HMA, a preliminary investigation was conducted among expert REL hematologists, asking for modifications of SIE/SIES/GITMO criteria they used to select candidates for Venetoclax/HMA. While opinions among experts varied, a general consensus emerged on restricting SIE/SIES/GITMO criteria for ICT-unfit patients to an age limit of 80–85, cardiac function > 40%, and absence of recurrent lung infections, bronchiectasis, or exacerbating COPD. Also, the presence of an adequate caregiver was considered mandatory. Such expert opinions may be clinically useful and may be considered when treatment-specific fitness criteria are updated to include Venetoclax/HMA.

Published
2024

4. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Author

Passamonti, Francesco, Cattaneo, Chiara, Arcaini, Luca, Bruna, Riccardo, Cavo, Michele, Merli, Francesco, Angelucci, Emanuele, Krampera, Mauro, Cairoli, Roberto, Della Porta, Matteo Giovanni, Fracchiolla, Nicola, Ladetto, Marco, Gambacorti Passerini, Carlo, Salvini, Marco, Marchetti, Monia, Lemoli, Roberto, Molteni, Alfredo, Busca, Alessandro, Cuneo, Antonio, Romano, Alessandra, Giuliani, Nicola, Galimberti, Sara, Corso, Alessandro, Morotti, Alessandro, Falini, Brunangelo, Billio, Atto, Gherlinzoni, Filippo, Visani, Giuseppe, Tisi, Maria Chiara, Tafuri, Agostino, Tosi, Patrizia, Lanza, Francesco, Massaia, Massimo, Turrini, Mauro, Ferrara, Felicetto, Gurrieri, Carmela, Vallisa, Daniele, Martelli, Maurizio, Derenzini, Enrico, Guarini, Attilio, Conconi, Annarita, Cuccaro, Annarosa, Cudillo, Laura, Russo, Domenico, Ciambelli, Fabrizio, Scattolin, Anna Maria, Luppi, Mario, Selleri, Carmine, Ortu La Barbera, Elettra, Ferrandina, Celestino, Di Renzo, Nicola, Olivieri, Attilio, Bocchia, Monica, Gentile, Massimo, Marchesi, Francesco, Musto, Pellegrino, Federici, Augusto Bramante, Candoni, Anna, Venditti, Adriano, Fava, Carmen, Pinto, Antonio, Galieni, Piero, Rigacci, Luigi, Armiento, Daniele, Pane, Fabrizio, Oberti, Margherita, Zappasodi, Patrizia, Visco, Carlo, Franchi, Matteo, Grossi, Paolo Antonio, Bertù, Lorenza, Corrao, Giovanni, Pagano, Livio, and Corradini, Paolo

Published
2020
Full Text
View/download PDF

5. Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda

Author

Rossi, Giuseppe, primary, Borlenghi, Erika, additional, Zappasodi, Patrizia, additional, Lussana, Federico, additional, Bernardi, Massimo, additional, Basilico, Claudia, additional, Molteni, Alfredo, additional, Lotesoriere, Ivana, additional, Turrini, Mauro, additional, Frigeni, Marco, additional, Fumagalli, Monica, additional, Cozzi, Paola, additional, Gigli, Federica, additional, Cattaneo, Chiara, additional, Fracchiolla, Nicola Stefano, additional, Riva, Marta, additional, Martini, Gianluca, additional, Mancini, Valentina, additional, Cairoli, Roberto, additional, and Todisco, Elisabetta, additional

Published
2024
Full Text
View/download PDF

7. Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study

Author

Schettini, Francesco, Sobhani, Navid, Ianza, Anna, Triulzi, Tiziana, Molteni, Alfredo, Lazzari, Maria Chiara, Strina, Carla, Milani, Manuela, Corona, Silvia Paola, Sirico, Marianna, Bernocchi, Ottavia, Giudici, Fabiola, Cappelletti, Maria Rosaria, Ciruelos, Eva, Jerusalem, Guy, Loi, Sherine, Fox, Stephen B., and Generali, Daniele

Published
2020
Full Text
View/download PDF

8. Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients

Author

Maffioli, Margherita, Giorgino, Toni, Mora, Barbara, Iurlo, Alessandra, Elli, Elena, Finazzi, Maria Chiara, Caramella, Marianna, Rumi, Elisa, Carraro, Maria Cristina, Polverelli, Nicola, D'Adda, Mariella, Malato, Simona, Rossi, Marianna, Molteni, Alfredo, Vismara, Alessandro, Sissa, Cinzia, Spina, Francesco, Anghilieri, Michela, Cattaneo, Daniele, Renso, Rossella, Bellini, Marta, Pioltelli, Maria Luisa, Cavalloni, Chiara, Barraco, Daniela, Accetta, Raffaella, Bertù, Lorenza, Della Porta, Matteo Giovanni, and Passamonti, Francesco

Published
2019
Full Text
View/download PDF

10. Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)

Author

Oliva, Esther Natalie, primary, Riva, Marta, additional, Niscola, Pasquale, additional, Santini, Valeria, additional, Breccia, Massimo, additional, Giai, Valentina, additional, Poloni, Antonella, additional, Patriarca, Andrea, additional, Crisà, Elena, additional, Capodanno, Isabella, additional, Salutari, Prassede, additional, Reda, Gianluigi, additional, Cascavilla, Nicola, additional, Ferrero, Dario, additional, Guarini, Attilio, additional, Tripepi, Giovanni, additional, Iannì, Giuseppe, additional, Russo, Emilio, additional, Castelli, Andrea, additional, Fattizzo, Bruno, additional, Beltrami, Germana, additional, Bocchia, Monica, additional, Molteni, Alfredo, additional, Fenaux, Pierre, additional, Germing, Ulrich, additional, Ricco, Alessandra, additional, Palumbo, Giuseppe A., additional, Impera, Stefana, additional, Di Renzo, Nicola, additional, Rivellini, Flavia, additional, Buccisano, Francesco, additional, Stamatoullas-Bastard, Aspasia, additional, Liberati, Anna Marina, additional, Candoni, Anna, additional, Delfino, Ilaria Maria, additional, Arcadi, Maria Teresa, additional, Cufari, Patrizia, additional, Rizzo, Lorenzo, additional, Bova, Irene, additional, D'Errigo, Maria Grazia, additional, Zini, Gina, additional, and Latagliata, Roberto, additional

Published
2023
Full Text
View/download PDF

11. Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes

Author

Falconi, Giulia, Fabiani, Emiliano, Piciocchi, Alfonso, Criscuolo, Marianna, Fianchi, Luana, Lindfors Rossi, Elisa L., Finelli, Carlo, Cerqui, Elisa, Ottone, Tiziana, Molteni, Alfredo, Parma, Matteo, Santarone, Stella, Candoni, Anna, Sica, Simona, Leone, Giuseppe, Lo-Coco, Francesco, and Voso, Maria Teresa

Published
2019
Full Text
View/download PDF

12. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Author

Oliva, Esther N, Alati, Caterina, Santini, Valeria, Poloni, Antonella, Molteni, Alfredo, Niscola, Pasquale, Salvi, Flavia, Sanpaolo, Grazia, Balleari, Enrico, Germing, Ulrich, Fenaux, Pierre, Stamatoullas, Aspasia, Palumbo, Giuseppe A, Salutari, Prassede, Impera, Stefana, Avanzini, Paolo, Cortelezzi, Agostino, Liberati, Anna Marina, Carluccio, Paola, Buccisano, Francesco, Voso, Maria Teresa, Mancini, Stefano, Kulasekararaj, Austin, Morabito, Fortunato, Bocchia, Monica, Cufari, Patrizia, Spiriti, Maria Antonietta Aloe, Santacaterina, Irene, D'Errigo, Maria Grazia, Bova, Irene, Zini, Gina, and Latagliata, Roberto

Published
2017
Full Text
View/download PDF

13. Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase-II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)

Author

Oliva, Esther Natalie, Riva, Marta, Niscola, Pasquale, Santini, Valeria, Breccia, Massimo, Giai, Valentina, Poloni, Antonella, Patriarca, Andrea, Crisà, Elena, Capodanno, Isabella, Salutari, Prassede, Reda, Gianluigi, Cascavilla, Nicola, Ferrero, Dario, Guarini, Attilio, Tripepi, Giovanni, Iannì, Giuseppe, Russo, Emilio, Castelli, Andrea, Fattizzo, Bruno, Beltrami, Germana, Bocchia, Monica, Molteni, Alfredo, Fenaux, Pierre, Germing, Ulrich, Ricco, Alessandra, Palumbo, Giuseppe A, Impera, Stefana, Di Renzo, Nicola, Rivellini, Flavia, Buccisano, Francesco, Stamatoullas-Bastard, Aspasia, Liberati, Anna Marina, Candoni, Anna, Delfino, Ilaria Maria, Arcadi, Maria Teresa, Cufari, Patrizia, Rizzo, Lorenzo, Bova, Irene, D'Errigo, Maria Grazia, Zini, Gina, and Latagliata, Roberto

Subjects
Settore MED/15
Published
2023

14. AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia

Author

Todisco, Elisabetta, Papayannidis, Cristina, Fracchiolla, Nicola, Petracci, Elisabetta, Zingaretti, Chiara, Vetro, Calogero, Martelli, Maria Paola, Zappasodi, Patrizia, Di Renzo, Nicola, Gallo, Susanna, Audisio, Ernesta, Griguolo, Davide, Cerchione, Claudio, Selleri, Carmine, Mattei, Daniele, Bernardi, Massimo, Fumagalli, Monica, Rizzuto, Giuliana, Facchini, Luca, Basilico, Claudia Maria, Manfra, Ilenia, Borlenghi, Erika, Cairoli, Roberto, Salutari, Prassede, Gottardi, Michele, Molteni, Alfredo, Martini, Vincenza, Lunghi, Monia, Fianchi, Luana, Cilloni, Daniela, Lanza, Francesco, Abruzzese, Elisabetta, Cascavilla, Nicola, Rivellini, Flavia, Ferrara, Felicetto, Maurillo, Luca, Nanni, Jacopo, Romano, Alessandra, Cardinali, Valeria, Gigli, Federica, Roncoroni, Elisa, Federico, Vincenzo, Marconi, Giovanni, Volpi, Roberta, Sciumè, Mariarita, Tarella, Corrado, Rossi, Giuseppe, Martinelli, Giovanni, Todisco, Elisabetta, Papayannidis, Cristina, Fracchiolla, Nicola, Petracci, Elisabetta, Zingaretti, Chiara, Vetro, Calogero, Martelli, Maria Paola, Zappasodi, Patrizia, Di Renzo, Nicola, Gallo, Susanna, Audisio, Ernesta, Griguolo, Davide, Cerchione, Claudio, Selleri, Carmine, Mattei, Daniele, Bernardi, Massimo, Fumagalli, Monica, Rizzuto, Giuliana, Facchini, Luca, Basilico, Claudia Maria, Manfra, Ilenia, Borlenghi, Erika, Cairoli, Roberto, Salutari, Prassede, Gottardi, Michele, Molteni, Alfredo, Martini, Vincenza, Lunghi, Monia, Fianchi, Luana, Cilloni, Daniela, Lanza, Francesco, Abruzzese, Elisabetta, Cascavilla, Nicola, Rivellini, Flavia, Ferrara, Felicetto, Maurillo, Luca, Nanni, Jacopo, Romano, Alessandra, Cardinali, Valeria, Gigli, Federica, Roncoroni, Elisa, Federico, Vincenzo, Marconi, Giovanni, Volpi, Roberta, Sciumè, Mariarita, Tarella, Corrado, Rossi, Giuseppe, Martinelli, Giovanni, Todisco, E, Papayannidis, C, Fracchiolla, N, Petracci, E, Zingaretti, C, Vetro, C, Martelli, M, Zappasodi, P, Di Renzo, N, Gallo, S, Audisio, E, Griguolo, D, Cerchione, C, Selleri, C, Mattei, D, Bernardi, M, Fumagalli, M, Rizzuto, G, Facchini, L, Basilico, C, Manfra, I, Borlenghi, E, Cairoli, R, Salutari, P, Gottardi, M, Molteni, A, Martini, V, Lunghi, M, Fianchi, L, Cilloni, D, Lanza, F, Abruzzese, E, Cascavilla, N, Rivellini, F, Ferrara, F, Maurillo, L, Nanni, J, Romano, A, Cardinali, V, Gigli, F, Roncoroni, E, Federico, V, Marconi, G, Volpi, R, Sciumè, M, Tarella, C, Rossi, G, and Martinelli, G

Subjects
Cancer Research, hypomethylating agents, Oncology, hypomethylating agent, relapsed and refractory AML, venetoclax, real-life data, acute myeloid leukemia
Abstract

Background: Venetoclax in combination with hypomethylating agents (HMA) is revolutionizing the therapy of acute myeloid leukemia (AML). However, evidence on large sets of patients is lacking, especially in relapsed or refractory leukemia. Methods: AVALON is a multicentric cohort study that was conducted in Italy on patients with AML who received venetoclax-based therapies from 2015 to 2020. The study was approved by the ethics committee of the participating institution and was conducted in accordance with the Declaration of Helsinki. The effectiveness and toxicity of venetoclax+HMA in 190 (43 newly diagnosed, 68 refractory, and 79 relapsed) patients with AML are reported here. Results: In the newly diagnosed AML, the overall response rate and survival confirmed the brilliant results demonstrated in VIALE-A. In the relapsed or refractory AML, the combination demonstrated a surprisingly complete remission rate (44.1% in refractory and 39.7% in relapsed evaluable patients) and conferred to treated patients a good expectation of survival. Toxicities were overall manageable, and most incidents occurred in the first 60days of therapy. Infections were confirmed as the most common nonhematologic adverse event. Conclusions: Real-life data show that the combination of venetoclax and HMA offers an expectation of remission and long-term survival to elderly, newly diagnosed patients, and to relapsed or chemoresistant AML, increasing the chance of cure through a different mechanism of action. The venetoclax+HMA combination is expected to constitute the base for triplet combinations and integration of target therapies. Our data contribute to ameliorate the understanding of venetoclax+HMA effectiveness and toxicities in real life.

Published
2023

15. Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an “Old-fashioned” Drug be Effective?

Author

Riva, Marta, primary, Bosi, Alessandro, additional, Rizzo, Lorenzo, additional, Mazzon, Federico, additional, Ferrari, Silvia, additional, Lussana, Federico, additional, Borin, Lorenza, additional, Castelli, Andrea, additional, Cairoli, Roberto, additional, Barcellini, Wilma, additional, Molteni, Alfredo, additional, and Fattizzo, Bruno, additional

Published
2023
Full Text
View/download PDF

16. Multiparametric Flow Cytometry-MRD Assay: Lesson from Phase II Trail REL AML 001

Author

Gatti, A, Veronese, S, Grillo, G, Di Camillo, B, Fumagalli, M, Krampera, M, Zappasodi, P, Borlenghi, E, Todisco, E, Ubezio, M, Bernardi, M, Molteni, A, Basilico, C, Turrini, M, Greco, R, Mancini, V, Riva, M, Magliano, G, Stefanucci, M, Brando, B, Beghini, A, Cairoli, R, Gatti, Arianna, Veronese, Silvio, Grillo, Giovanni, Di Camillo, Barbara, Fumagalli, Monica, Krampera, Mauro, Zappasodi, Patrizia, Borlenghi, Erika, Todisco, Elisabetta, Ubezio, Marta, Bernardi, Massimo, Molteni, Alfredo, Basilico, Claudia, Turrini, Mauro, Greco, Rosa, Mancini, Valentina, Riva, Marta, Magliano, Gabriele, Stefanucci, Marta Rachele, Brando, Bruno, Beghini, Alessandro, Cairoli, Roberto, Gatti, A, Veronese, S, Grillo, G, Di Camillo, B, Fumagalli, M, Krampera, M, Zappasodi, P, Borlenghi, E, Todisco, E, Ubezio, M, Bernardi, M, Molteni, A, Basilico, C, Turrini, M, Greco, R, Mancini, V, Riva, M, Magliano, G, Stefanucci, M, Brando, B, Beghini, A, Cairoli, R, Gatti, Arianna, Veronese, Silvio, Grillo, Giovanni, Di Camillo, Barbara, Fumagalli, Monica, Krampera, Mauro, Zappasodi, Patrizia, Borlenghi, Erika, Todisco, Elisabetta, Ubezio, Marta, Bernardi, Massimo, Molteni, Alfredo, Basilico, Claudia, Turrini, Mauro, Greco, Rosa, Mancini, Valentina, Riva, Marta, Magliano, Gabriele, Stefanucci, Marta Rachele, Brando, Bruno, Beghini, Alessandro, and Cairoli, Roberto

Published
2023

17. Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an 'Old-fashioned' Drug be Effective?

Author

Riva, M, Bosi, A, Rizzo, L, Mazzon, F, Ferrari, S, Lussana, F, Borin, L, Castelli, A, Cairoli, R, Barcellini, W, Molteni, A, Fattizzo, B, Riva, Marta, Bosi, Alessandro, Rizzo, Lorenzo, Mazzon, Federico, Ferrari, Silvia, Lussana, Federico, Borin, Lorenza, Castelli, Andrea, Cairoli, Roberto, Barcellini, Wilma, Molteni, Alfredo, Fattizzo, Bruno, Riva, M, Bosi, A, Rizzo, L, Mazzon, F, Ferrari, S, Lussana, F, Borin, L, Castelli, A, Cairoli, R, Barcellini, W, Molteni, A, Fattizzo, B, Riva, Marta, Bosi, Alessandro, Rizzo, Lorenzo, Mazzon, Federico, Ferrari, Silvia, Lussana, Federico, Borin, Lorenza, Castelli, Andrea, Cairoli, Roberto, Barcellini, Wilma, Molteni, Alfredo, and Fattizzo, Bruno

Published
2023

18. The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the “Rete Ematologica Lombarda”

Author

Molteni, Alfredo, Riva, Marta, Borin, Lorenza, Bernardi, Massimo, Pelizzari, Anna Maria, Freyrie, Alessandra, Porta, Matteo Della, Nichelatti, Michele, Ravano, Emanuele, Quaresmini, Giulia, Mariotti, Jacopo, Caramazza, Domenica, Ubezio, Marta, Guarco, Simona, Gigli, Federica, Greco, Rosa, Cairoli, Roberto, and Morra, Enrica

Published
2016
Full Text
View/download PDF

20. Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS)

Author

Lanino, Luca, primary, Salutari, Prassede, additional, Perego, Alessandra, additional, Fattizzo, Bruno, additional, Riva, Marta, additional, Ubezio, Marta, additional, Musto, Pellegrino, additional, Cilloni, Daniela, additional, Oliva, Esther Natalie, additional, Voso, Maria Teresa, additional, Pelizzari, Anna Maria, additional, Poloni, Antonella, additional, Capodanno, Isabella, additional, Elena, Chiara, additional, Fozza, Claudio, additional, Pane, Fabrizio, additional, Breccia, Massimo, additional, De Gobbi, Marco, additional, Di Bassiano, Francesco, additional, Barraco, Daniela, additional, Crisà, Elena, additional, Ferrero, Dario, additional, Frairia, Chiara, additional, Vaccarino, Antonella, additional, Griguolo, Davide, additional, Paolini, Stefania, additional, Quintini, Martina, additional, Sessa, Mariarosaria, additional, Turrini, Mauro, additional, Bocchia, Monica, additional, Di Renzo, Nicola, additional, Diral, Elisa, additional, Foli, Cristina, additional, Molteni, Alfredo, additional, Occhini, Ubaldo, additional, Rivoli, Giulia, additional, Selleri, Carmine, additional, Bono, Roberto, additional, Calvisi, Anna, additional, Castelli, Andrea, additional, Di Bona, Eros, additional, Di Veroli, Ambra, additional, Fianchi, Luana, additional, Galimberti, Sara, additional, Grimaldi, Daniele, additional, Marchetti, Monia, additional, Norata, Marianna, additional, Rambaldi, Alessandro, additional, Tanasi, Ilaria, additional, Tosi, Patrizia, additional, Naldi, Ilaria, additional, Santini, Valeria, additional, and Della Porta, Matteo G., additional

Published
2022
Full Text
View/download PDF

21. Evolutionary Portrait of Adult Core-Binding Factor Leukemia Patients Treated with a Continuation Therapy with Midostaurin: Preliminary Results

Author

Cairoli, Roberto, primary, Gatti, Arianna, additional, Grillo, Giovanni, additional, Fumagalli, Monica, additional, Krampera, Mauro, additional, Zappasodi, Patrizia, additional, Borlenghi, Erika, additional, Todisco, Elisabetta, additional, Ubezio, Marta, additional, Bernardi, Massimo, additional, Molteni, Alfredo, additional, Basilico, Claudia, additional, Turrini, Mauro, additional, Greco, Rosa, additional, Mancini, Valentina, additional, Riva, Marta, additional, De Marco, Beatrice, additional, Stefanucci, Marta Rachele, additional, Brando, Bruno, additional, Veronese, Silvio Marco, additional, and Beghini, Alessandro, additional

Published
2022
Full Text
View/download PDF

22. Efficacy and Safety of Danazol in Patients with Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms: A Multicenter Observational Study

Author

Bosi, Alessandro, primary, Fattizzo, Bruno, additional, Rizzo, Lorenzo, additional, Ferrari, Silvia, additional, Lussana, Federico, additional, Borin, Lorenza Maria, additional, Castelli, Andrea, additional, Bianchi, Paola, additional, Barcellini, Wilma, additional, Cairoli, Roberto, additional, Molteni, Alfredo, additional, and Riva, Marta, additional

Published
2022
Full Text
View/download PDF

23. Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Treatment of Myeloproliferative Neoplasms in Blastic Phase (MPN-BP) and Acute Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Author

Latagliata, Roberto, primary, Cristiano, Gianluca, additional, Lama, Dorela, additional, Fenu, Susanna, additional, Rizzo, Lorenzo, additional, Cambò, Benedetta, additional, Zoletto, Simone, additional, Spirito, Francesca, additional, Cavalca, Fabrizio, additional, Cattaneo, Daniele, additional, Cenfra, Natalia, additional, De Luca, Giulia, additional, Esposito Vangone, Beatrice, additional, Di Veroli, Ambra, additional, Palmieri, Raffaele, additional, Annunziata, Mario, additional, Mulas, Olga, additional, Abruzzese, Elisabetta, additional, Molteni, Alfredo, additional, Piedimonte, Monica, additional, Carmosino, Ida, additional, Salutari, Prassede, additional, Biagi, Annalisa, additional, Bocchia, Monica, additional, Santopietro, Michelina, additional, Binotto, Gianni, additional, Iurlo, Alessandra, additional, Crugnola, Monica, additional, Riva, Marta, additional, Piccioni, Anna Lina, additional, Elli, Elena Maria, additional, Curti, Antonio, additional, and Poloni, Antonella, additional

Published
2022
Full Text
View/download PDF

25. Real-World Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anaemia Due to Lower-Risk Myelodysplastic Syndromes with Ring Sideroblasts (MDS-RS), Who Had an Unsatisfactory Response to or are Ineligible for Erythropoiesis Stimulating Agents: A Retrospective, Multicenter, Cohort Study

Author

Lanino, Luca, primary, Restuccia, Francesco, additional, Perego, Alessandra, additional, Ubezio, Marta, additional, Fattizzo, Bruno, additional, Riva, Marta, additional, Consagra, Angela, additional, Musto, Pellegrino, additional, Cilloni, Daniela, additional, Oliva, Esther Natalie, additional, Palmieri, Raffaele, additional, Poloni, Antonella, additional, Califano, Catello, additional, Capodanno, Isabella, additional, Itri, Federico, additional, Elena, Chiara, additional, Fozza, Claudio, additional, Pane, Fabrizio, additional, Pelizzari, Anna Maria, additional, Breccia, Massimo, additional, Di Bassiano, Francesco, additional, Crisa, Elena, additional, Ferrero, Dario, additional, Giai, Valentina, additional, Barraco, Daniela, additional, Vaccarino, Antonella, additional, Griguolo, Davide, additional, Minetto, Paola, additional, Martina, Quintini, additional, Paolini, Stefania, additional, Sanpaolo, Grazia, additional, Sessa, Mariarosaria, additional, Bocchia, Monica, additional, Di Renzo, Nicola, additional, Diral, Elisa, additional, Leuzzi, Livia, additional, Genua, Angelo, additional, Guarini, Attilio, additional, Molteni, Alfredo, additional, Nicolino, Barbara, additional, Occhini, Ubaldo, additional, Rivoli, Giulia, additional, Bono, Roberto, additional, Calvisi, Anna, additional, Castelli, Andrea, additional, Di Bona, Eros, additional, Di Veroli, Ambra, additional, Ferrara, Felicetto, additional, Fianchi, Luana, additional, Galimberti, Sara, additional, Grimaldi, Daniele, additional, Marchetti, Monia, additional, Norata, Marianna, additional, Frigeni, Marco, additional, Sancetta, Rosaria, additional, Selleri, Carmine, additional, Tanasi, Ilaria, additional, Tosi, Patrizia, additional, Turrini, Mauro, additional, Giordano, Laura, additional, Finelli, Carlo, additional, Pasini, Paolo, additional, Naldi, Ilaria, additional, Santini, Valeria, additional, and Della Porta, Matteo, additional

Published
2022
Full Text
View/download PDF

26. Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy

Author

Efficace, Fabio, Santini, Valeria, La Nasa, Giorgio, Cottone, Francesco, Finelli, Carlo, Borin, Lorenza, Quaresmini, Giulia, Di Tucci, Anna Angela, Volpe, Antonio, Cilloni, Daniela, Quarta, Giovanni, Sanpaolo, Grazia, Rivellini, Flavia, Salvi, Flavia, Molteni, Alfredo, Voso, Maria Teresa, Alimena, Giuliana, Fenu, Susanna, Mandelli, Franco, and Angelucci, Emanuele

Published
2016
Full Text
View/download PDF

30. JAK Inhibition with Ruxolitinib in Patients with COVID-19 and Severe Pneumonia: Multicenter Clinical Experience from a Compassionate Use Program in Italy

Author

Vannucchi, Alessandro Maria, primary, Mortara, Andrea, additional, D’Alessio, Andrea, additional, Morelli, Mara, additional, Tedeschi, Alberto, additional, Festuccia, Moreno Benedetto, additional, Monforte, Antonella D’Arminio, additional, Capochiani, Enrico, additional, Selleri, Carmine, additional, Simonetti, Federico, additional, Saracino, Annalisa, additional, Rapezzi, Davide, additional, Badagliacca, Maria Rita, additional, Falasca, Katia, additional, Molteni, Alfredo, additional, Palazzolo, Roberto, additional, Schettino, Giuliano, additional, Bocchia, Monica, additional, Turrini, Mauro, additional, Ascierto, Paolo A., additional, Zuurman, Mike, additional, Paley, Carole, additional, Coco, Paola, additional, and Saglio, Giuseppe, additional

Published
2021
Full Text
View/download PDF

31. Combined renal proximal tubulopathy and crystal storing histiocytosis in a patient with κ light chain multiple myeloma

Author

Ungari, Marco, primary, Ghiringhelli, Paolo, additional, Marchi, Gianluca, additional, Fisogni, Simona, additional, Lavazza, Antonio, additional, Molteni, Alfredo, additional, Malberti, Fabio, additional, Bertoni, Ramona, additional, Trombatore, Monica, additional, Ferrero, Giuseppina, additional, Gusolfino, Marino Daniel, additional, Varotti, Elena, additional, Tanzi, Giulia, additional, and Manotti, Laura, additional

Published
2021
Full Text
View/download PDF

32. Nilotinib‐induced bone marrow CD34+/lin‐Ph+ cells early clearance in newly diagnosed CP‐Chronic Myeloid Leukemia: Final report of the PhilosoPhi34 study

Author

Pungolino, Ester, primary, D'adda, Mariella, additional, De Canal, Gabriella, additional, Trojani, Alessandra, additional, Perego, Alessandra, additional, Elena, Chiara, additional, Lunghi, Francesca, additional, Turrini, Mauro, additional, Borin, Lorenza, additional, Iurlo, Alessandra, additional, Latargia, Maria Luisa, additional, Carraro, Maria Cristina, additional, Spina, Francesco, additional, Artale, Salvatore, additional, Anghilieri, Michela, additional, Molteni, Alfredo, additional, Caramella, Marianna, additional, Baruzzo, Giacomo, additional, Nichelatti, Michele, additional, Di Camillo, Barbara, additional, and Cairoli, Roberto, additional

Published
2021
Full Text
View/download PDF

33. Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial

Author

Schettini, Francesco, primary, Corona, Silvia Paola, additional, Giudici, Fabiola, additional, Strina, Carla, additional, Sirico, Marianna, additional, Bernocchi, Ottavia, additional, Milani, Manuela, additional, Ziglioli, Nicoletta, additional, Aguggini, Sergio, additional, Azzini, Carlo, additional, Barbieri, Giuseppina, additional, Cervoni, Valeria, additional, Cappelletti, Maria Rosa, additional, Molteni, Alfredo, additional, Lazzari, Maria Chiara, additional, Ferrero, Giuseppina, additional, Ungari, Marco, additional, Marasco, Elena, additional, Bruson, Alice, additional, Xumerle, Luciano, additional, Zago, Elisa, additional, Cerra, Davide, additional, Loddo, Marco, additional, Williams, Gareth H., additional, Paris, Ida, additional, Scambia, Giovanni, additional, and Generali, Daniele, additional

Published
2021
Full Text
View/download PDF

34. Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Therapy of Acute Myeloid Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Author

Latagliata, Roberto, Cambò, Benedetta, Piccioni, Anna Lina, Federico, Vincenzo, Cristiano, Gianluca, Lugli, Elisabetta, Rizzo, Lorenzo, Santopietro, Michelina, Mazzone, Carla, Bonifacio, Massimiliano, Palmieri, Raffaele, Poloni, Antonella, Biagi, Annalisa, Binotto, Gianni, Delfina, Marzia, Annunziata, Mario, Molteni, Alfredo, Piedimonte, Monica, Carmosino, Ida, Di Veroli, Ambra, Niscola, Pasquale, Riva, Marta, Capodanno, Isabella, Curti, Antonio, Di Rienzo, Nicola, Fenu, Susanna, and Crugnola, Monica

Published
2023
Full Text
View/download PDF

35. SIE/Sies/GITMO Criteria in Elderly Patients with Acute Myeloid Leukemia (AML): Useful Also in the New Drug Era? a Multicentric Real-Life Study By the Hematological Network Rete Ematologica Lombarda (REL)

Author

Borlenghi, Erika, Masina, Lorenzo, Frigeni, Marco, Lotesoriere, Ivana, Molteni, Alfredo, Fumagalli, Monica, Riva, Marta, Zappasodi, Patrizia, Bernardi, Massimo, Fracchiolla, Nicola, Gigli, Federica, Basilico, Claudia, Pagani, Chiara, Lussana, Federico, Perfetti, Paola, Cattaneo, Chiara, Tajana, Monica, Viola, Silvia, Martini, Gianluca, Catalano, Gloria, Sciumè, Mariarita, Condorelli, Annalisa, Cela, Giselda, Rossi, Giuseppe, Tucci, Alessandra, Cairoli, Roberto, and Todisco, Elisabetta

Published
2023
Full Text
View/download PDF

36. Multiparametric Flow Cytometry-MRD Assay: Lesson from Phase II Trail REL AML 001

Author

Gatti, Arianna, Veronese, Silvio, Grillo, Giovanni, Di Camillo, Barbara, Fumagalli, Monica, Krampera, Mauro, Zappasodi, Patrizia, Borlenghi, Erika, Todisco, Elisabetta, Ubezio, Marta, Bernardi, Massimo, Molteni, Alfredo, Basilico, Claudia, Turrini, Mauro, Greco, Rosa, Mancini, Valentina, Riva, Marta, Magliano, Gabriele, Stefanucci, Marta Rachele, Brando, Bruno, Beghini, Alessandro, and Cairoli, Roberto

Published
2023
Full Text
View/download PDF

38. Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)

Author

Angelucci, Emanuele, Santini, Valeria, Di Tucci, Anna Angela, Quaresmini, Giulia, Finelli, Carlo, Volpe, Antonio, Quarta, Giovanni, Rivellini, Flavia, Sanpaolo, Grazia, Cilloni, Daniela, Salvi, Flavia, Caocci, Giovanni, Molteni, Alfredo, Vallisa, Daniele, Voso, Maria Teresa, Fenu, Susanna, Borin, Lorenza, Latte, Giancarlo, Alimena, Giuliana, Storti, Sergio, Piciocchi, Alfonso, Fazi, Paola, Vignetti, Marco, and Tura, Sante

Published
2014
Full Text
View/download PDF

39. Prospective Evaluation of a Continuation Therapy with Midostaurin in Adult Patients with Core-Binding Factor Leukemia and Integrated Genetic Analysis: A Multi Center Phase II Study. Preliminary Results

Author

Cairoli, Roberto, primary, Krampera, Mauro, additional, Zappasodi, Patrizia, additional, Todisco, Elisabetta, additional, Borlenghi, Erika, additional, Molteni, Alfredo, additional, Fumagalli, Monica, additional, Ubezio, Marta, additional, Bernardi, Massimo, additional, Greco, Rosa, additional, Ravelli, Erika, additional, Mancini, Valentina, additional, Grillo, Giovanni, additional, Riva, Marta, additional, De Marco, Beatrice, additional, Cassaro, Adriana, additional, Brando, Bruno, additional, Gatti, Arianna, additional, Veronese, Silvio Marco, additional, and Beghini, Alessandro, additional

Published
2020
Full Text
View/download PDF

40. SARS-CoV-2 in Myelodysplastic Syndromes: A Snapshot From Early Italian Experience

Author

Mossuto, Sandra, primary, Attardi, Enrico, additional, Alesiani, Francesco, additional, Angelucci, Emanuele, additional, Balleari, Enrico, additional, Bernardi, Massimo, additional, Binotto, Gianni, additional, Bosi, Costanza, additional, Calvisi, Anna, additional, Capodanno, Isabella, additional, Carbone, Antonella, additional, Castelli, Andrea, additional, Cerrano, Marco, additional, Ciancia, Rosanna, additional, Cilloni, Daniela, additional, Clavio, Marino, additional, Clissa, Cristina, additional, Crisà, Elena, additional, Crugnola, Monica, additional, Della Porta, Matteo G., additional, Di Renzo, Nicola, additional, Di Veroli, Ambra, additional, Fattizzo, Roberto, additional, Fava, Carmen, additional, Fenu, Susanna, additional, Ferrara, Ida L., additional, Fianchi, Luana, additional, Filì, Carla, additional, Finelli, Carlo, additional, Giai, Valentina, additional, Frattini, Francesco, additional, Gaidano, Valentina, additional, Guaragna, Gianluca, additional, Gumenyuk, Svitlana, additional, Latagliata, Roberto, additional, Mancini, Stefano, additional, Messa, Emanuela, additional, Molteni, Alfredo, additional, Musto, Pellegrino, additional, Niscola, Pasquale, additional, Oliva, Esther, additional, Palumbo, Giuseppe A., additional, Pelizzari, Annamaria, additional, Pilo, Federica, additional, Poloni, Antonella, additional, Riva, Marta, additional, Rivellini, Flavia, additional, Sarlo, Chiara, additional, Sciumé, Mariarita, additional, Secchi, Roberto, additional, Selleri, Carmine, additional, Tafuri, Agostino, additional, and Santini, Valeria, additional

Published
2020
Full Text
View/download PDF

41. Reply to 'CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report' Analysis of six hematological centers in Lombardy

Author

Reda, Gianluigi, Noto, Alessandro, Cassin, Ramona, Zamprogna, Giulia, Borella, Chiara, Scarfò, Lydia, Farina, Lucia, Molteni, Alfredo, Ghia, Paolo, Tedeschi, Alessandra, and Montillo, Marco

Subjects
Male, Cancer Research, Pneumonia, Viral, Antineoplastic Agents, Antiviral Agents, Fibrin Fibrinogen Degradation Products, Betacoronavirus, Medical research, Piperidines, Lymphopenia, Correspondence, Prevalence, Humans, Signs and symptoms, Pandemics, Protein Kinase Inhibitors, Aged, Aged, 80 and over, SARS-CoV-2, Adenine, Age Factors, COVID-19, Hematology, Middle Aged, Leukemia, Lymphocytic, Chronic, B-Cell, Survival Analysis, Pyrimidines, Oncology, Spain, Ferritins, Disease Progression, Pyrazoles, Female, Coronavirus Infections, Biomarkers, Hydroxychloroquine
Published
2020

42. Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial

Author

Oliva, Esther Natalie, primary, Alati, Caterina, additional, Santini, Valeria, additional, Poloni, Antonella, additional, Riva, Marta, additional, Niscola, Pasquale, additional, Giai, Valentina, additional, Sanpaolo, Grazia, additional, Balleari, Enrico, additional, Crisà, Elena, additional, Ferrero, Dario, additional, Germing, Ulrich, additional, Fenaux, Pierre, additional, Palumbo, Giuseppe A., additional, Salutari, Prassede, additional, Impera, Stefana, additional, Capodanno, Isabella, additional, Reda, Gianluigi, additional, Liberati, Anna Marina, additional, Molteni, Alfredo, additional, Specchia, Giorgina, additional, Buccisano, Francesco, additional, Voso, Maria Teresa, additional, Mancini, Stefano, additional, Bocchia, Monica, additional, Candoni, Anna, additional, Martino, Bruno, additional, Cufari, Patrizia, additional, D'Errigo, Maria Grazia, additional, Zini, Gina, additional, and Latagliata, Roberto, additional

Published
2019
Full Text
View/download PDF

43. Real-Rd - Real Life Italian Experience with Lenalidomide and Low-Dose Dexamethasone (Rd) As First Line Treatment of Newly-Diagnosed Multiple Myeloma Patients Not Eligible to Stem Cell Transplantation: Outcomes and Tolerability

Author

Pompa, Alessandra, primary, Conticello, Concetta, additional, Giannarelli, Diana, additional, Pettine, Loredana, additional, Paris, Laura, additional, Tognazzi, Lucia, additional, Marcatti, Magda, additional, Antonioli, Elisabetta, additional, Fioritoni, Francesca, additional, Bonalumi, Angela, additional, Mangiacavalli, Silvia, additional, Bertazzoni, Paola, additional, Vincelli, Iolanda Donatella, additional, Derudas, Daniele, additional, Siniscalchi, Agostina, additional, Pezzatti, Sara, additional, Zambello, Renato, additional, Citro, Annalisa, additional, Belotti, Angelo, additional, Lombardo, Alessandra, additional, Vozella, Federico, additional, Sementa, Adelina, additional, Consoli, Ugo, additional, Molteni, Alfredo, additional, Frungillo, Niccolò, additional, Gentile, Massimo, additional, Buda, Gabriele, additional, Aquino, Sara, additional, Palmieri, Salvatore, additional, Bongarzoni, Velia, additional, Inzoli, Alessandro, additional, Ferla, Valeria, additional, Rossi, Francesca Gaia, additional, Leotta, Valerio, additional, Romano, Alessandra, additional, Elia, Federica, additional, Del Fabro, Vittorio, additional, Montanaro, Guido, additional, Cavallaro, Francesca, additional, Galli, Monica, additional, and Baldini, Luca, additional

Published
2019
Full Text
View/download PDF

44. Clinical Relevance of Individual Response to Iron Chelation Therapy (ICT) in Patients with Myelodysplastic Syndromes (MDS) and Transfusion Requirement

Author

Latagliata, Roberto, primary, Niscola, Pasquale, additional, Oliva, Esther Natalie, additional, Riva, Marta, additional, Capodanno, Isabella, additional, Volpe, Antonio, additional, Pilo, Federica, additional, Baratè, Claudia, additional, Campagna, Alessia, additional, Pelizzari, Anna Maria, additional, Poloni, Antonella, additional, Sarlo, Chiara, additional, Mansueto, Giovanna, additional, Piccioni, Anna Lina, additional, Rosati, Serena, additional, Carmosino, Ida, additional, Carbone, Antonella, additional, Tognazzi, Lucia, additional, Salutari, Prassede, additional, Mancini, Annalisa, additional, Cuffari, Patrizia, additional, Pennese, Elsa, additional, Fenu, Susanna, additional, Aloe Spiriti, Maria Antonietta, additional, Galimberti, Sara, additional, Molteni, Alfredo, additional, Balleari, Enrico, additional, Breccia, Massimo, additional, Foà, Robin, additional, Maurillo, Luca, additional, and Finelli, Carlo, additional

Published
2019
Full Text
View/download PDF

45. Real‐world experience with decitabine as a first‐line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy

Author

Bocchia, Monica, primary, Candoni, Anna, additional, Borlenghi, Erika, additional, Defina, Marzia, additional, Filì, Carla, additional, Cattaneo, Chiara, additional, Sammartano, Vincenzo, additional, Fanin, Renato, additional, Sciumè, Margherita, additional, Sicuranza, Anna, additional, Imbergamo, Silvia, additional, Riva, Marta, additional, Fracchiolla, Nicola, additional, Latagliata, Roberto, additional, Caizzi, Emanuela, additional, Mazziotta, Francesco, additional, Alunni, Giulia, additional, Di Bona, Eros, additional, Crugnola, Monica, additional, Rossi, Marianna, additional, Consoli, Ugo, additional, Fontanelli, Giulia, additional, Greco, Giuseppina, additional, Nadali, Gianpaolo, additional, Rotondo, Francesco, additional, Todisco, Elisabetta, additional, Bigazzi, Catia, additional, Capochiani, Enrico, additional, Molteni, Alfredo, additional, Bernardi, Massimo, additional, Fumagalli, Monica, additional, Rondoni, Michela, additional, Scappini, Barbara, additional, Ermacora, Anna, additional, Simonetti, Federico, additional, Gottardi, Michele, additional, Lambertenghi Deliliers, Daniela, additional, Michieli, Mariagrazia, additional, Basilico, Claudia, additional, Galeone, Carlotta, additional, Pelucchi, Claudio, additional, and Rossi, Giuseppe, additional

Published
2019
Full Text
View/download PDF

47. P53 and CD34 Immunohistochemical Expression on Bone Marrow Biopsy As Predictive Marker of Response to Erythropoietin in Low Risk Myelodysplastic Syndrome

Author

Reda, Gianluigi, primary, Boggio, Francesca, additional, Cassin, Ramona, additional, Riva, Marta, additional, Barella, Marco, additional, del Gobbo, Alessandro, additional, Bandiera, Laura, additional, Bonoldi, Emanuela, additional, Molteni, Alfredo, additional, Cortelezzi, Agostino, additional, and Gianelli, Umberto, additional

Published
2018
Full Text
View/download PDF

49. Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS)

Author

Fabiani, Emiliano, primary, Calabrese, Chiara, additional, Niscola, Pasquale, additional, Balleari, Enrico, additional, Molteni, Alfredo, additional, Finelli, Carlo, additional, Falconi, Giulia, additional, Fenu, Susanna, additional, Fianchi, Luana, additional, Criscuolo, Marianna, additional, Salvi, Flavia, additional, Lavorgna, Serena, additional, Buccisano, Francesco, additional, Maurillo, Luca, additional, Lo Coco, Francesco, additional, Cilloni, Daniela, additional, and Voso, Maria Teresa, additional

Published
2018
Full Text
View/download PDF

50. Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes

Author

Falconi, Giulia, primary, Fabiani, Emiliano, additional, Piciocchi, Alfonso, additional, Criscuolo, Marianna, additional, Fianchi, Luana, additional, Lindfors Rossi, Elisa L., additional, Finelli, Carlo, additional, Cerqui, Elisa, additional, Ottone, Tiziana, additional, Molteni, Alfredo, additional, Parma, Matteo, additional, Santarone, Stella, additional, Candoni, Anna, additional, Sica, Simona, additional, Leone, Giuseppe, additional, Lo-Coco, Francesco, additional, and Voso, Maria Teresa, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results